by AIP Online Bureau | Mar 12, 2026 | Eco/Invest/Demography, Health, Indian News, Regulation
Promotional activities, including what it described as “so-called (obesity) awareness campaigns” that function as surrogate advertisements for prescription drugs, could be treated as misleading marketing practices, according to the advisory. India is...
by AIP Online Bureau | Feb 26, 2026 | Articles, Eco/Invest/Demography, Health, Pension & Social Security
Obesity is a serious medical problem as it is associated with cardiovascular diseases, hypertension, hepatic steatosis, sleep apnea syndrome, metabolic abnormalities like type 2 diabetes or dyslipidemia, musculoskeletal disorders, or even cancer (especially colon,...
by AIP Online Bureau | Dec 28, 2025 | Data, Eco/Invest/Demography, Health
“Improving access to GLP-1 treatments in the coming years will be a key driver for the Indian pharmaceutical industry, helping address the growing burden of lifestyle diseases such as obesity and diabetes. Combined with AI-enabled digital tools for early disease...
by AIP Online Bureau | Nov 27, 2025 | Data, Eco/Invest/Demography, Health, Non-Life
The report also called for four key actions to tackle the menace. These include strengthening food environment regulation to reduce the consumption of high-fat, sugar, and salt products New Delhi: Obesity and related chronic diseases account for a growing share of...
by AIP Online Bureau | Sep 1, 2025 | Data, Health
Obesity in India affects more than 250 million adults and is linked to over 230 health complications, including cardiovascular disease, diabetes, cancer and obstructive sleep apnoea, the company said. New Delhi: Denmark-based healthcare firm Novo Nordisk on Monday...
